Overview
Yuki Akazawa practices in Osaka, Japan. Akazawa is rated as an Experienced expert by MediFind in the treatment of Antisynthetase Syndrome. Their top areas of expertise are Lung Cancer, EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Thrombectomy.
Their clinical research consists of co-authoring 27 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Antisynthetase Syndrome.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- EGFR Positive Lung CancerAkazawa isAdvanced. Learn about EGFR Positive Lung Cancer.
- Lung CancerAkazawa isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Antisynthetase SyndromeAkazawa isExperienced. Learn about Antisynthetase Syndrome.
- Hypersensitivity PneumonitisAkazawa isExperienced. Learn about Hypersensitivity Pneumonitis.
- Lung AdenocarcinomaAkazawa isExperienced. Learn about Lung Adenocarcinoma.
- Lung MetastasesAkazawa isExperienced. Learn about Lung Metastases.
- Small Cell Lung Cancer (SCLC)Akazawa isExperienced. Learn about Small Cell Lung Cancer (SCLC).
- ThrombectomyAkazawa isExperienced. Learn about Thrombectomy.